[1] |
Syrja NS, Shabalova IP, Petrovichev N, et al.Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the Former Soviet Union[J]. J Low Genit Tract Dis, 2002, 6(2):97-110.
|
[2] |
柴淑霞. 宫颈癌流行病学及高危因素探讨[J]. 世界最新医学信息文摘, 2017(63):196-197.
|
[3] |
石岩. 宫颈癌流行病学特征和高危因素的相关研究[J]. 中国保健营养, 2019, 29(7):114.
|
[4] |
Louvanto K,Chevarie-Davis M, Ramanakumar AV, et al. HPV testing with cytology triage for cervical cancer screening in routine practice [J].Am J Obstet Gynecol,2014,210(5) :474. e l -474. e7.
|
[5] |
Zorzi M, Del Mistro A, Farruggio A, et al.Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme:A population-based cohort study[J]. BJOG, 2013, 120(10) :1260-1267.
|
[6] |
Kitchener H, Canfell K, Gilham C, et al.The clinical effectiveness and cost - effectiveness of primary human papillomavirus cervical screening in England:Extended follow-up of the ARTISTIC random ised trial cohort through three screening rounds[J]. Health Technol Assess,2014,18(23):1-196.
|
[7] |
范江诺, 范江华, 尚仁香. 2009年海阳市部分乡镇医院妇科门诊农村妇女高危型人乳头状瘤病毒DNA检测与细胞学联合检查情况调查[J]. 中华妇幼临床医学杂志(电子版), 2011,7(3):181-184.
|
[8] |
李美琴, 马玉琴, 范玉芳. 液基细胞学检查、阴道镜下宫颈活检在宫颈上皮内瘤变中的诊断价值[J]. 苏州大学学报:医学版, 2009, 29(6):1238-1239.
|
[9] |
Yu B,Xu PZ,Wang QW,et al.Relationship between human papilloma virus and cervical carcinoma[J].Chin J Gen Pract,2009,8:238-240.
|
[10] |
王宏伟, 胡吉东. 人乳头瘤病毒感染与宫颈病变的结果分析[J]. 中国药物与临床, 2019, 19(4):664-666.
|
[11] |
Cappelli MG, Fortunato F, Tafuri S, et al.Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination[J]. Eur J Cancer Care (Engl),2018,27(5):905-907.
|
[12] |
刘童童, 李顺平. 国内外宫颈癌筛查障碍研究综述[J]. 中国社会医学杂志, 2018, 35(1):92-95.
|
[13] |
Richard G.Cervical cancer screening[J]. Clin Obstet Gynecol, 2018, 61(1):40-51.
|
[14] |
Rees I, Jones D, Chen H, et al.Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: A systematic review[J]. Prev Med,2018,111:323-335.
|
[15] |
王全师. 18F-FDG PET/CT在宫颈癌中的临床价值[J]. 中华核医学与分子影像杂志, 2015,35(3):161-163.
|
[16] |
Zhao FH, Lewkowitz AK, Hu SY, et al.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population-based studied[J].Int J Caner,2013,133(6):2929-2938.
|
[17] |
唐努尔·阿不力米提, 帕提曼·米吉提, 古里给娜·阿布都热西提. TCT和HC2-HPV-DNA宫颈癌筛查法在临床的应用效果比较[J]. 癌症进展, 2016, 14(8): 802-804.
|
[18] |
张二春. 液基细胞学技术结合高危型HPV检测对宫颈癌前病变诊断的效果[J]. 中国妇幼保健,2013,28(31):5214-5216.
|
[19] |
舒小芳,蔡婷英,施敏伟,等.缙云县2 166例妇女宫颈癌筛查结果分析[J].中国公共卫生管理,2020,36(3):437-439.
|
[20] |
聂文佳, 牛凤霞, 王朝卿, 等. 河北省10 111例宫颈薄层液基细胞学检查结果及诊断分析[J]. 中国热带医学, 2019, 19(4): 377-381.
|
[21] |
王兰英, 施姚, 张生枝, 等. E6/E7 mRNA检测在高危型人乳头瘤病毒DNA阳性且细胞学轻度异常患者随访中的作用[J]. 温州医科大学学报, 2018, 48(11): 818-821,827.
|
[22] |
蓝家富. 防城港市2 292例女性宫颈HPV感染与基因分型分析[J].分子诊断与治疗杂志,2019,11(3):204-208.
|